As per MRFR Analysis, the Veterinary Laboratory Testing Market was valued at USD 7.42 Billion in 2023 and is projected to grow to USD 18.93 Billion by 2032, with a CAGR of 10.99% from 2024 to 2032. The market is driven by advancements in diagnostic technologies and increasing pet ownership. Key players like IDEXX and Synlab are expanding their offerings, while innovations such as mobile diagnostic services are enhancing accessibility for pet owners. The market is segmented by animal type, technology, product, and end user, with significant growth expected in the companion animal segment and among veterinary hospitals and clinics.
The Veterinary Laboratory Testing Market is witnessing significant growth driven by technological advancements and increasing pet health awareness.
IDEXX Laboratories, Synlab, PepiPets, Companion Animal Health, Ringbio
In Europe and Asia, IDEXX has launched the SNAP Leish 4Dx Test which is used for screening vector-borne diseases such as canine leishmaniosis. This product launch expands the company’s offering in this sector. The ability to diagnose animal diseases has been increased significantly by continuous advancements in veterinary diagnostic technologies like molecular diagnostics, imaging modalities, and PoC testing.
For example, Synlab-a German diagnostics firm involved in human and pet health-accepted to sell its animal health diagnostics operations to Mars Inc., sometime in August 2023. This would allow Synlab to concentrate on its core competencies while SYNLAB VET was predicted to prosper under the stewardship of Mars.
In August 2022, PepiPets started providing a mobile diagnostic testing service. By launching this new service through a company announcement, pet owners can get their pets tested at home for diseases. PepiPets also expects that the at-home testing service will make animals more comfortable with the procedure and cut time spent traveling to an office visit.
In March 2022, Companion Animal Health announced an equity investment and strategic agreement with HT BioImaging to co-brand and exclusively sell the HTVet product within Canada and the United States.
Also worth noting is that Ringbio launched petrapidtest.com as a professional website for marketing the Flexy Pet Rapid Test in January 2022. Some of these kits are based on lateral flow immunoassay, ELISA or real-time PCR methods intended for the detection of companion animal diseases; hence, they may be advantageous both for animal keepers and vet clinics. Real-time PCR among these products was particularly designed for small vet clinics, which can detect infections like viruses, mycoplasma, parasite infections etc. It is important to note that the segment’s growth has also been augmented by activities such as advertising by these players.
Veterinary healthcare refers to a subset of science that deals with diagnosing, treating, and preventing various diseases in animals to expand their lifespan. It involves several services, including regular monitoring of animal health and deployment of medicated animal feeds, diagnostic products, drugs, and vaccines for limiting the spread of zoonotic diseases among animals and people. These amenities are extensively provided by the sole traders, pharmacies, veterinary hospitals, clinics, and laboratory testing services. Veterinary healthcare facilities are available for both companions and livestock animals.
The global veterinary healthcare market is driven by the increasing prevalence of various zoonotic, food-borne, and chronic diseases, such as cancer, especially among cats and dogs. This is further supported by the emerging trend of pet humanization and the increasing concerns of pet owners toward animal health, which, in turn, is facilitating the demand for preventive and more sophisticated veterinary services and therapeutic and diagnostics treatments. In line with this, significant technological advancements, such as introducing veterinary health information systems for efficient data management, are another growth-inducing factor. These devices assist in diagnosing animal health, facilitating real-time analysis of disease fluctuations, recording information on cloud-based platforms, and sharing essential veterinary clinic-generated data with clinicians and researchers directly through the internet.
The veterinary laboratory testing market has been segmented into animal type, technology, product, and end user.
The market, on the basis of animal type, has been segmented into companion animal and livestock animal. The companion animal segment is further classified as dogs, cats, horses and others. The livestock animal segment is further classified as cattle, pigs, poultry and others.
The market, by technology, has been segmented into clinical biochemistry, immunodiagnostics, hematology, molecular diagnostics, urinalysis, and others.
The clinical biochemistry segment is further classified as clinical chemistry analysis, glucose monitoring, and blood gas & electrolyte analysis. The clinical chemistry analysis segment includes clinical chemistry reagent clips and cartridges and clinical chemistry analyzers. The glucose monitoring segment includes blood glucose strips, glucose monitors and urine glucose strips. The blood gas & electrolyte analysis segment includes blood gas and electrolyte reagent clips and cartridges and blood gas & electrolyte analyzers.
The immunodiagnostics segment is further classified as ELISA tests, lateral flow assays, allergen-specific immunodiagnostic tests, immunoassay analyzers, and others. The lateral flow assays segment includes lateral flow rapid tests, and lateral flow strip readers.
The hematology segment is further classified as hematology cartridges, and hematology analyzers.
The molecular diagnostics segment is further classified as polymerase chain reaction (PCR) tests, microarrays, and others.
The urinalysis segment is further classified as urinalysis clips & cartridges/panels, urine analyzers, and urine test strips.
The market, by product, has been segmented into consumables and instruments.
The market, by end user, has been segmented into veterinary hospitals & clinics, in-house testing, research institutes, diagnostic laboratories, and others. The veterinary hospitals & clinics segment held the largest segment of the market in 2017. This can be attributed to the increasing incidence of zoonotic diseases. On the other hand, the academic institutes segment is estimated to be the fastest growing segment.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market of veterinary laboratory testing in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European veterinary laboratory testing market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The market of veterinary laboratory testing in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market of veterinary laboratory testing in the Middle East & Africa has been segmented into the Middle East and Africa.
Geographically, the Americas is anticipated to dominate the veterinary laboratory testing market owing to increasing cases of animal disease and technological advancements in veterinary diagnostics.
For instance, in 2016, IDEXX Laboratories, Inc. launched the Rapid Visual Pregnancy Test for cattle. With the new test, veterinarians can more quickly identify open cows using whole blood samples collected before the farm visit.
Europe is expected to hold the second largest position in the market of veterinary laboratory testing . The market growth in this region is attributed to the rising expenditure on pet insurance.
The Veterinary Laboratory Testing Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the awareness regarding use of sterile consumables for lab testing and rising healthcare spending.
The Middle East & Africa contributes least in the global market for veterinary laboratory testing.
Veterinary Laboratory Testing Region Outlook
Veterinary Laboratory Testing Market by Key Players
Recent Development
May 2020
In May 2020, the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratories confirmed SARS-CoV-2 in one tiger at a zoo in New York. As per the World Organization for Animal Health, as of 2020, there are approximately 117 animal diseases, infections, and infestations. In addition, with the rising pet ownership and increasing awareness, the veterinary diagnostics market is expected to grow over the forecast period.
Intended Audience
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 7.42 Billion |
| Market Size 2024 | USD 8.22 Billion |
| Market Size 2032 | USD 18.93 Billion |
| CAGR | 10.99% |
| Base Year | 2021 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Animal type, Technology, Product, and End user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Abaxis Inc., BIOCHECK Inc., Biomérieux SA, Henry Schein Inc., Heska Corporation, Idexx Laboratories, Idvet, Neogen Corporation, Pfizer, Qiagen N.V., Randox Laboratories Ltd., Thermo Fisher Scientific, VCA Inc., Virbac, Zoetis Inc. |
| Key Market Opportunities | Rising incidence of zoonotic diseases |
| Key Market Drivers | Rising awareness about animal diseases Technological advancements in veterinary testing Increasing expenditure on pet insurance Favourable funding policies |
Veterinary Laboratory Testing Market Highlights:
Frequently Asked Questions (FAQ) :
The veterinary laboratory testing market is expected to reach USD 18.93 billion by 2032.
The veterinary laboratory testing market is expected to exhibit a solid 10.99% CAGR over the forecast period from 2024 to 2032.
The growing prevalence of zoonotic diseases is the major driver for the veterinary laboratory testing market.
The Americas market holds the largest share in the global veterinary laboratory testing market, followed by Europe, due to the widespread awareness about veterinary diseases and laboratory testing.
Leading players in the veterinary laboratory testing market include Abaxis Inc., Henry Schein Inc., Heska Corporation, Idvet, Neogen Corporation, and Pfizer, among others.
Veterinary laboratory testing market is expected grow USD 15.8 Billion at a CAGR 10.4% during the forecast period.
$15.8 Billion
10.4%
North America
2022-2030
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
